Heterophile Antibody Interference led to Unneeded Chemotherapy in a Testicular Cancer Patient.

Urol Case Rep

Department of Medical Oncology, APREC (Alliance Pour la Recherche En Cancérologie), Hospital Tenon (Public Assistance - Paris Hospitals, AP-HP), 4, rue de la Chine, 75970 Paris Cedex 20, France; Sorbonne Universities, University Pierre et Marie Curie (IUC-UPMC Univ. Paris 06), France.

Published: November 2016

Human heterophile antibodies may develop after infection or contact with animal tissues or animal serum products. These antibodies have the capacity to bind to the animal immunoglobulins used in immunoassays leading to erroneous results. We here report a case of a testicular germ cell tumor patient who developed heterophile antibodies during the surveillance period of his disease. Following false-positive results of human chorionic gonadotropin (hCG) he received unneeded chemotherapy. This article also stresses the problem of using serum tumor markers without no major imaging abnormalities to diagnose a patients' relapse.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007586PMC
http://dx.doi.org/10.1016/j.eucr.2016.07.006DOI Listing

Publication Analysis

Top Keywords

unneeded chemotherapy
8
heterophile antibodies
8
heterophile antibody
4
antibody interference
4
interference led
4
led unneeded
4
chemotherapy testicular
4
testicular cancer
4
cancer patient
4
patient human
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!